Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Engeroff

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The Journal of Allergy and Clinical Immunology|December 14, 2020
Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine modelPaul Engeroff, Kevin Plattner, Federico Storni, et al.
Frontiers in Immunology|June 10, 2024
Interleukin-1 regulates follicular T cells during the germinal center reactionAude Belbezier, Paul Engeroff, Gwladys Fourcade, et al.
Vaccines|September 27, 2025
Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and SpecificityDominik A Rothen, Alessandro Pardini, Sudip Kumar Dutta, et al.
NPJ Vaccines|December 22, 2017
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergyAndris Zeltins, Jonathan West, Franziska Zabel, et al.
Vaccines|May 5, 2017
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivaxGustavo Cabral-Miranda, Matthew D Heath, Mona O Mohsen, et al.
The Journal of Allergy and Clinical Immunology|December 24, 2019
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergensFederico Storni, Andris Zeltins, Ina Balke, et al.
JCI Insight|May 20, 2025
IL-1β Signaling modulates T follicular helper and regulatory cells in human lymphoid tissuesRomain Vaineau, Raphaël Jeger-Madiot, Samir Ali-Moussa, et al.
Vaccines|March 27, 2026
Virus-like and Virus Replicon Particles Targeting Multiple B-Cell Antigens Do Not Protect Against African Swine Fever VirusKirill Lotonin, Obdulio García-Nicolás, Normann Kilb, et al.
Journal for Immunotherapy of Cancer|May 25, 2019
Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancerMona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, et al.
Journal for Immunotherapy of Cancer|April 28, 2019
Vaccination with nanoparticles combined with micro-adjuvants protects against cancerMona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Allergy and Clinical Immunology|December 14, 2020
Glycan-specific IgG anti-IgE autoantibodies are protective against allergic anaphylaxis in a murine modelPaul Engeroff, Kevin Plattner, Federico Storni, et al.
Frontiers in Immunology|June 10, 2024
Interleukin-1 regulates follicular T cells during the germinal center reactionAude Belbezier, Paul Engeroff, Gwladys Fourcade, et al.
Vaccines|September 27, 2025
Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and SpecificityDominik A Rothen, Alessandro Pardini, Sudip Kumar Dutta, et al.
NPJ Vaccines|December 22, 2017
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergyAndris Zeltins, Jonathan West, Franziska Zabel, et al.
Vaccines|May 5, 2017
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivaxGustavo Cabral-Miranda, Matthew D Heath, Mona O Mohsen, et al.
The Journal of Allergy and Clinical Immunology|December 24, 2019
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergensFederico Storni, Andris Zeltins, Ina Balke, et al.
JCI Insight|May 20, 2025
IL-1β Signaling modulates T follicular helper and regulatory cells in human lymphoid tissuesRomain Vaineau, Raphaël Jeger-Madiot, Samir Ali-Moussa, et al.
Vaccines|March 27, 2026
Virus-like and Virus Replicon Particles Targeting Multiple B-Cell Antigens Do Not Protect Against African Swine Fever VirusKirill Lotonin, Obdulio García-Nicolás, Normann Kilb, et al.
Journal for Immunotherapy of Cancer|May 25, 2019
Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancerMona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, et al.
Journal for Immunotherapy of Cancer|April 28, 2019
Vaccination with nanoparticles combined with micro-adjuvants protects against cancerMona O Mohsen, Matthew D Heath, Gustavo Cabral-Miranda, et al.
Pageof 3